Meghan CarozzaMember, Exposure Therapy · Co-Founder | Good Kitty Co

Dr Meg - Cofounder of Good Kitty - 70% of UTI Antibiotics are multidrug resistance

21 Feb 2025 · 1 min

Watch on YouTube

1:00

In this brief monologue, Dr. Meg (co‑founder of Good Kitty) highlights the alarming rise of multidrug‑resistant (MDR) Escherichia coli, which now accounts for up to 90% of urinary tract infections (UTIs) in sexually active women and is resistant to multiple antibiotics in up to 70% of cases. She underscores antibiotics as a historic medical triumph but warns that the World Health Organization has flagged MDR bacteria as a top global public‑health threat. Dr. Meg explains that repeated or long‑term antibiotic use can foster resistant strains within an individual’s own microbiome, potentially rendering future infections untreatable. To address this, she introduces Good Kitty’s product, UTI Biome Shield, a preventative supplement designed to protect the urinary microbiome and reduce the need for antibiotics, thereby preserving their effectiveness.

Chapters

Data from the last decade shows that E. coli is now responsible for up to 90% of UTIs in sexually active women. Up to 70% of E. coli is now multidrug-resistant. This is crazy. Antibiotics are a godsend. They represent one of the greatest achievements in the history of science, and they have saved millions of lives. And when you need antibiotics for a UTI, you have to take the antibiotics. But the World Health Organization is now calling multidrug resistance one of the greatest public health problems facing the world today. And look, this isn't just a them problem. On a personal individual level, the repeated and long-term use of antibiotics can breed resistant strains that could over time become impossible to treat in your own body. And that's why we developed our product, UTI Biome Shield, to give women like us the tools to be proactive and stop UTIs before they start so that when you actually need the antibiotics, they still work.